Ofloxacin 0.3%. <6mos: not established. Otitis externa: 6mos–13yrs: 5 drops in ... in affected ear(s) twice daily for 14 days. Formerly known under the brand name Floxin Otic.
Ofloxacin Otic Solution 0.3 per cent is used as anti-infective (antibacterial) for otic (ear) use. According to IQVIATM (IMS Health), Ofloxacin Otic Solution 0.3 per cent had US sales of ...
XTORO is a New Chemical Entity that is FDA approved for the treatment of acute otitis externa, commonly known as "swimmer’s ear", caused by susceptible strains of Pseudomonas aeruginosa and ...
XTORO is a New Chemical Entity that is FDA approved for the treatment of acute otitis externa, commonly known as “swimmer’s ear”, caused ... XTORO® (finafloxacin otic suspension) 0.3% ...
Fonseca Biosciences (“Fonseca”) announced today an agreement with MerLion Pharmaceuticals GmbH granting Fonseca the exclusive rights to market and distribute XTORO ® (finafloxacin otic ...